Artios Pharma
Developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to selectively kill cancer cells. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€556—835m (Dealroom.co estimates Jul 2021.)
Company register number 09931309
Babraham England (HQ)
Authorizing premium user...